全文获取类型
收费全文 | 914篇 |
免费 | 0篇 |
国内免费 | 2篇 |
专业分类
电工技术 | 1篇 |
化学工业 | 6篇 |
金属工艺 | 2篇 |
能源动力 | 2篇 |
水利工程 | 1篇 |
无线电 | 5篇 |
一般工业技术 | 2篇 |
冶金工业 | 893篇 |
自动化技术 | 4篇 |
出版年
2014年 | 1篇 |
2013年 | 1篇 |
2009年 | 1篇 |
2005年 | 2篇 |
2004年 | 2篇 |
2003年 | 2篇 |
2002年 | 1篇 |
2001年 | 1篇 |
2000年 | 2篇 |
1999年 | 28篇 |
1998年 | 285篇 |
1997年 | 160篇 |
1996年 | 111篇 |
1995年 | 72篇 |
1994年 | 46篇 |
1993年 | 54篇 |
1992年 | 8篇 |
1991年 | 13篇 |
1990年 | 12篇 |
1989年 | 15篇 |
1988年 | 11篇 |
1987年 | 9篇 |
1986年 | 7篇 |
1985年 | 14篇 |
1983年 | 1篇 |
1982年 | 4篇 |
1981年 | 3篇 |
1980年 | 8篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1977年 | 18篇 |
1976年 | 20篇 |
1975年 | 2篇 |
排序方式: 共有916条查询结果,搜索用时 9 毫秒
11.
12.
PURPOSE: The phenoxyacetic acid, ethacrynic acid (ECA), has potential use in glaucoma therapy because it acts to increase aqueous outflow in vivo and in vitro. In human trabecular meshwork (HTM) cell culture, ECA acts to change cell shape and attachment, effects that have been correlated with microtubule (MT) alterations and chemical sulfhydryl (SH) reactivity. To further explore these actions, we evaluated two non-SH reactive phenoxyacetic acids, inadcrinone and ticrynafen, and the MT-disrupting drug vinblastine. METHODS: Excised bovine and porcine eyes were perfused and outflow facility measured. Calf pulmonary artery endothelial and HTM cells were grown in culture and cytoskeletal effects evaluated after drug treatment. RESULTS: Indacrinone, ticrynafen, and vinblastine all caused an increase in outflow facility. In contrast with ECA, the outflow effects of indacrinone and ticrynafen were not blocked by excess cysteine. Although indacrinone and ticrynafen produced changes in cell shape in vitro, the beta-tubulin staining pattern of treated cells was not altered. Vinblastine caused cell shape change and the expected MT disruption. CONCLUSIONS: Phenoxyacetic acids can increase aqueous outflow facility and alter HTM cell shape and attachment in vitro by a non-SH, non-MT mechanism (which is probably shared also by ECA). These findings suggest the possibility of a broader class of glaucoma drugs that may be directed at the HTM. An understanding of the cellular target for these drugs has implications both for potential glaucoma therapy and for the cytoskeletal mechanisms involved in normal outflow function. 相似文献
13.
HA Mook DM Paul BC Sales LA Boatner L Cussen 《Canadian Metallurgical Quarterly》1988,38(16):12008-12010
14.
15.
16.
17.
18.
JK Kang SW Lee MW Baik BC Son YK Hong CK Jung KH Ryu 《Canadian Metallurgical Quarterly》1998,14(7):297-301
Accurate assessment and replacement of blood loss and fluid-electrolyte deficit during craniosynostosis repair is difficult owing to patient size and the diversity of surgical technique. Forty-three patients undergoing primary craniosynostosis repair over a 10-year period were studied retrospectively to determine blood loss and fluid deficit and to assess blood transfusion practices during both intraoperative and postoperative periods. Blood loss was calculated on the basis of estimated red cell mass (ERCM) and fluid-electrolyte imbalance was investigated with blood samplings. Blood transfusion was considered appropriate if the postoperative or posttransfusion ERCM was within 12% of the preoperative value. Estimated fluid requirement (EFR) was used in 4 ml kg(-1) h(-1) except for neonates. Intraoperatively, 80% of all patients were appropriately managed with respect to blood transfusion and EFR. Postoperatively only 20% of the patients receiving transfusions were transfused appropriately. In 23.3% of these patients (10/43) unexpected respiratory distress developed immediately after their recovery from the anesthesia. With the measurement of estimated blood volume and allowable blood loss, appropriate transfusion could be achieved for the successful treatment of the primary craniosynostosis. 相似文献
19.
M Patel RF Kaltenbach DA Nugiel RJ McHugh PK Jadhav LT Bacheler BC Cordova RM Klabe S Erickson-Viitanen S Garber C Reid SP Seitz 《Canadian Metallurgical Quarterly》1998,8(9):1077-1082
Cyclic urea SD146, a potent HIV protease inhibitor bearing a flat resistance profile, possessed poor solubility and bioavailability, which precluded further development of the compound. In an effort to improve upon the pharmacokinetic profile of the compound, several analogs modified at the P1/P1' residues were prepared and evaluated. Several of those compounds displayed significant improvement of physical properties. 相似文献
20.